Background Budd-Chiari syndrome (BCS) is an eponym that includes a group of conditions
characterized by partial or complete hepatic venous tract outflow obstruction, and the site of …

Purpose To assess the critical role of transjugular intrahepatic portosystemic shunt (TIPS) in
the management of Budd-Chiari syndrome (BCS), as the data with respect to the safety and …

Background and Aims Direct oral anticoagulants (DOACs) may simplify management of
Budd-Chiari syndrome (BCS). Here, we report our experience with off-label use of DOACs …

Budd-Chiari syndrome (BCS) is a rare hepatic vascular disorder defined by the presence of
partial or complete impairment of hepatic venous drainage in the absence of right heart …

Liver diseases are a major cause of illness and death worldwide. In China, liver diseases,
primarily viral hepatitis, affect approximately 300 million people, thus having a major impact …

Budd-Chiari syndrome (BCS) is an uncommon disease of the liver, characterised by
obstruction of the hepatic venous outflow tract. The etiological spectrum of BCS as well as …

Abstract Background Both Budd-Chiari syndrome (BCS) and portal vein thrombosis (PVT)
have been linked to various prothrombotic (PT) conditions. The PT profile in Asians is …

Myeloproliferative neoplasms (MPNs) are defined as clonal disorders of the hematopoietic
stem cell in which an exaggerated production of terminally differentiated myeloid cells …

(1) Background: Hepatic venous occlusion type of Budd–Chiari syndrome (BCS-HV) and
pyrrolizidine alkaloid-induced hepatic sinusoidal obstructive syndrome (PA-HSOS), share …

Splanchnic vein thrombosis (SVT) encompasses thrombosis in the vessels of the splanchnic
basin and has a relatively rare occurrence with a reported frequency in the general …